HomeInsightsStock Comparison

Intec Capital Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Intec Capital Ltd vs Novelix Pharmaceuticals Ltd Stock Comparison

Last Updated on: May 24, 2025

Key Highlights

  • The Latest Trading Price of Intec Capital Ltd is ₹ 16.98 as of 23 May 15:30.
  • The P/E Ratio of Intec Capital Ltd changed from 1.3 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Novelix Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Intec Capital Ltd changed from ₹ 61.8 crore on March 2020 to ₹ 31.02 crore on March 2024 . This represents a CAGR of -12.88% over 5 yearsThe Market Cap of Novelix Pharmaceuticals Ltd changed from ₹ 1.57 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The revenue of Intec Capital Ltd for the Dec '24 is ₹ 0.44 crore as compare to the Sep '24 revenue of ₹ 0.16 crore. This represent the growth of 175% The revenue of Novelix Pharmaceuticals Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Intec Capital Ltd for the Dec '24 is ₹ -0.2 crore as compare to the Sep '24 ebitda of ₹ -0.52 crore. This represent the decline of -61.54% The ebitda of Novelix Pharmaceuticals Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Intec Capital Ltd changed from ₹ -5.28 crore to ₹ -0.65 crore over 7 quarters. This represents a CAGR of -69.79% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Intec Capital Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Intec Capital Ltd

  • Intec Capital Limited was incorporated in India on February 15, 1994, was registered with Reserve Bank of India (RBI) as a Non-Banking Financial Company (NBFC) dated May 4, 1998 in the name of Intec Securities Limited.
  • Subsequently, due to change in name of the Company , it received a revised Certificate of Registration (CoR) in the name of Intec Capital Limited on November 4, 2009. Intec offers loan financing services.
  • The Company also offers services, including finance service, corporate advisory service and life/general insurance service.
  • Intec focuses on looking after the financial requirements of Small and Medium Enterprises (SMEs). The company is providing finance in the form of Assets Finance, Working Capital Finance and Loan against Property to SMEs.
  • Corporate advisory services provide personalized consulting, forecasts and advice for organizations.

About Novelix Pharmaceuticals Ltd

  • Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
  • Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
  • They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
  • Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.

Intec Capital Ltd News Hub

News

Intec Capital to conduct board meeting

Intec Capital will hold a meeting of the Board of Directors of the Company on 21 April 202...

Read more

16 Apr 2025 09:29

News

Intec Capital to conduct board meeting

Intec Capital will hold a meeting of the Board of Directors of the Company on 13 February ...

Read more

07 Feb 2025 15:58

News

Intec Capital to conduct board meeting

Intec Capital will hold a meeting of the Board of Directors of the Company on 20 January 2...

Read more

15 Jan 2025 10:47

News

Intec Capital to table results

Intec Capital will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

08 Nov 2024 16:20

News

Intec Capital AGM scheduled

Intec Capital announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

20 Sep 2024 17:47

News

Intec Capital schedules AGM

Intec Capital announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

20 Sep 2024 10:28

Novelix Pharmaceuticals Ltd News Hub

News

Novelix Pharmaceuticals to convene board meeting

Novelix Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 27...

Read more

21 May 2025 16:50

News

Novelix Pharmaceuticals to convene EGM

Novelix Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Comp...

Read more

15 Apr 2025 10:33

News

Trimurthi to table results

Trimurthi will hold a meeting of the Board of Directors of the Company on 12 February 2025...

Read more

08 Feb 2025 10:47

News

Trimurthi to announce Quarterly Result

Trimurthi will hold a meeting of the Board of Directors of the Company on 13 November 2024...

Read more

09 Nov 2024 17:04

News

Trimurthi revises board meeting date

Trimurthi has revised the meeting of the Board of Directors which was scheduled to be held...

Read more

14 Oct 2024 10:29

News

Trimurthi to hold board meeting

Trimurthi will hold a meeting of the Board of Directors of the Company on 14 October 2024....

Read more

08 Oct 2024 10:44

SWOT Analysis Of Novelix Pharmaceuticals Ltd

Strength

0

S

Weakness

0

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Intec Capital Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Novelix Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Intec Capital Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Intec Capital Ltd and Novelix Pharmaceuticals Ltd

Which company has a larger market capitalization, Intec Capital Ltd or Novelix Pharmaceuticals Ltd?

Market cap of Intec Capital Ltd is 31 Cr while Market cap of Novelix Pharmaceuticals Ltd is 69 Cr

What are the key factors driving the stock performance of Intec Capital Ltd and Novelix Pharmaceuticals Ltd?

The stock performance of Intec Capital Ltd and Novelix Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Intec Capital Ltd and Novelix Pharmaceuticals Ltd?

As of May 24, 2025, the Intec Capital Ltd stock price is INR ₹16.98. On the other hand, Novelix Pharmaceuticals Ltd stock price is INR ₹27.94.

How do dividend payouts of Intec Capital Ltd and Novelix Pharmaceuticals Ltd compare?

To compare the dividend payouts of Intec Capital Ltd and Novelix Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions